Deltex Medical Group PLC
13 May 2005
Deltex Medical Group plc
Directors' Shareholdings
Deltex Medical Group plc (the 'Company'), the AIM quoted haemodynamic monitoring
company, announces that Nigel Keen, Chairman and Ewan Phillips, Finance Director
yesterday purchased a total of 87,900 and 12,100 ordinary shares at an average
price of 19.2 pence per share respectively in the market.
The Company also announces that it has today issued a total of 98,518 new
ordinary shares in the Company to certain non-executive directors at a price of
203/4 pence per share based on yesterday's closing mid-market price.
The four non-executive directors named below have elected to take shares in lieu
of a cash payment as remuneration for their services to the Company.
Accordingly, application has been made for these shares to be admitted to
trading on AIM. The shares rank pari passu with the existing issued shares of
the Company and dealings are expected to commence on 20 May 2005. Following
these shares being admitted to trading on AIM, the number of shares in issue
will be 69,576,111.
Following the purchase of shares by the directors and the issue of new ordinary
shares, the directors' beneficial interests are as follows:
Name of Director Number of new Number of shares Holding of shares % of enlarged
ordinary shares purchased in following issue of issued share
issued in lieu of market new ordinary shares capital
fees and purchases in
market
Nigel Keen (1) 30,120 87,900 3,797,937 5.46%
Dr Edwin Snape (2) 21,687 - 3,116,706 4.48%
Peter Smedvig (3) 21,687 - 1,051,071 1.51%
Andy Hill - - 42,857 0.06%
Ewan Phillips - 12,100 477,814 0.69%
George Flouty 25,024 - 189,309 0.27%
Total 98,518 100,000 8,675,694 12.47%
(1) Includes 589,700 shares held as trustee and executor of Pauline Thomas
Charity Will Trust.
(2) Includes shares held as a director of New England Partners and
associated companies.
(3) Includes shares held as director of Peder Smedvig Capital AS.
For further information, please contact:-
Deltex Medical Group plc 01243 774 837
Nigel Keen, Chairman nigel.keen@deltexmedical.com
Andy Hill, Chief Executive andy.hill@deltexmedical.com
Ewan Phillips, Finance Director ewan.phillips@deltexmedical.com
Charles Stanley 0207 739 2000
Philip Davies
Financial Dynamics
David Yates/Lucy Briggs 0207 831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.